Irene Schiavetti

3.7k total citations · 1 hit paper
92 papers, 1.4k citations indexed

About

Irene Schiavetti is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Irene Schiavetti has authored 92 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 25 papers in Physiology and 22 papers in Pathology and Forensic Medicine. Recurrent topics in Irene Schiavetti's work include Asthma and respiratory diseases (25 papers), Multiple Sclerosis Research Studies (19 papers) and Respiratory and Cough-Related Research (17 papers). Irene Schiavetti is often cited by papers focused on Asthma and respiratory diseases (25 papers), Multiple Sclerosis Research Studies (19 papers) and Respiratory and Cough-Related Research (17 papers). Irene Schiavetti collaborates with scholars based in Italy, United States and United Kingdom. Irene Schiavetti's co-authors include Maria Pia Sormani, Giorgio Ciprandi, Fabio Luigi Massimo Ricciardolo, Alessio Signori, Alice Laroni, María Trojano, Gıancarlo Comı, Paola Zaratin, Marco Salvetti and Gioacchino Tedeschi and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Irene Schiavetti

77 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

2021 296 citations Maria Pia Sormani, Nicola De Rossi et al. Annals of Neurology profile →

Peers

Countries citing papers authored by Irene Schiavetti

Since Specialization

Citations

This map shows the geographic impact of Irene Schiavetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Schiavetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Schiavetti more than expected).

Fields of papers citing papers by Irene Schiavetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Schiavetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Schiavetti. The network helps show where Irene Schiavetti may publish in the future.

Co-authorship network of co-authors of Irene Schiavetti

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Schiavetti. A scholar is included among the top collaborators of Irene Schiavetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Schiavetti. Irene Schiavetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Increase in Functional Visual Loss: Another Side-Effect of the COVID-19 Pandemic? 2025 ·Life ·Andrea Lembo, Ilia Bresesti, (unknown), Irene Schiavetti, Paolo Nucci	0
2	Architectural atmospheres, priming effects and first impressions: a multi-perspective approach integrating self-report assessments and physiological responses 2025 ·Architectural Science Review ·(unknown), Zakaria Djebbara, (unknown), Luca Andrighetto, Irene Schiavetti, (unknown), Andrea Jelić, (unknown)	3
3	Uncovering a bias in estimated treatment effects on PIRA in multiple sclerosis clinical trials 2025 ·EBioMedicine ·(unknown), Francesca Bovis, Alessio Signori, (unknown), Irene Schiavetti, Marta Ponzano, Carmen Tur, Cristina Granziera, Alessandro Cagol, Douglas L. Arnold, Ludwig Kappos, Maria Pia Sormani	0
4	Comparison of the performance of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) and highly aspherical lenslets (HAL) spectacles 2024 ·BMJ Paediatrics Open ·Andrea Lembo, Irene Schiavetti, Massimiliano Serafino, (unknown), Paolo Nucci	2
5	Creating an automated tool for a consistent and repeatable evaluation of disability progression in clinical studies for multiple sclerosis 2024 ·Multiple Sclerosis Journal ·(unknown), Luca Carmisciano, Alessio Signori, Marta Ponzano, Irene Schiavetti, Francesca Bovis, Maria Pia Sormani	2
6	Therapeutic lag: Is treatment effect delayed in progressive MS? 2024 ·Multiple Sclerosis Journal ·(unknown), Francesca Bovis, Alessio Signori, Marta Ponzano, Irene Schiavetti, Maria Pia Sormani	2
7	Race and ethnicity in multiple sclerosis phase 3 clinical trials: A systematic review 2024 ·Multiple Sclerosis Journal ·Marta Ponzano, Alessio Signori, Andrea Bellavia, Alessio Carbone, Francesca Bovis, Irene Schiavetti, (unknown), Maria Pia Sormani	2
8	Assessing the duration of EDSS improvement after a therapy start: A novel approach applied to the long-term extension of the PRISMS study 2023 ·Multiple Sclerosis and Related Disorders ·Alessio Signori, Francesca Bovis, Irene Schiavetti, Marta Ponzano, Mark S. Freedman, (unknown), Nektaria Alexandri, Maria Pia Sormani	0
9	The Expression of Affective Temperaments in Cystic Fibrosis Patients: Psychopathological Associations and Possible Neurobiological Mechanisms 2023 ·Brain Sciences ·Andrea Amerio, (unknown), Carlo Castellani, Irene Schiavetti, (unknown), (unknown), (unknown), Rosaria Casciaro, Federico Cresta, Andrea Escelsior, Alessandra Costanza, Andrea Aguglia, Gianluca Serafini, Mario Amore, (unknown)	0
10	The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706) 2022 ·Journal of Immunology Research ·Lorenzo Drago, Luigi Cioffi, Maria Giuliano, Marco Pane, Angela Amoruso, Irene Schiavetti, Gregor Reid, Giorgio Ciprandi, (unknown)	39
11	Hard Ticks (Ixodidae) from Wildlife in Liguria, Northwest Italy: Tick Species Diversity and Tick-Host Associations 2022 ·Insects ·(unknown), Irene Schiavetti, Valeria Listorti, (unknown), (unknown), Carlo Ercolini, Lisa Guardone, Elisabetta Razzuoli	9
12	Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up 2022 ·European Journal of Neurology ·(unknown), Irene Dogliotti, (unknown), Davide Bertuzzo, Giulia Benevolo, Lorella Orsucci, Irene Schiavetti, (unknown), Federica Cavallo, (unknown), Alessandra Di Liberto, (unknown), (unknown), Carlo Alberto Artusi, Daniela Drandi, Leonardo Lopiano, Bruno Ferrero, Simone Ferrero	9
13	Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis breakdown → 2021 ·Annals of Neurology ·Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti, (unknown), Cinzia Cordioli, Lucia Moiola, (unknown), Paolo Immovilli, Marco Capobianco, María Trojano, Paola Zaratin, Gioacchino Tedeschi, Gıancarlo Comı, Mario Alberto Battaglia, Francesco Patti, Marco Salvetti, (unknown)	296
14	Different disease modifying therapies can increase or decrease Covid-19 severity in Multiple Sclerosis (2021) 2021 ·Neurology ·Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli, Lucia Moiola, Marta Radaelli, Paolo Immovilli, Marco Capobianco, María Trojano, Paola Zaratin, (unknown), Giancarlo Comi, Mario Alberto Battaglia, Francesco Patti, Marco Salvetti	4
15	COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments 2020 ·Multiple Sclerosis Journal ·Alice Laroni, Irene Schiavetti, Maria Pia Sormani, Antonio Uccelli	25
16	Oral Administration of S-Adenosylmethionine (SAMe) and Lactobacillus Plantarum HEAL9 Improves the Mild-To-Moderate Symptoms of Depression 2020 ·The Primary Care Companion For CNS Disorders ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Paolo Picco, (unknown), Roberta Montisci, Irene Schiavetti, (unknown)	32
17	Pixel or Paper? Validation of a Mobile Technology for Collecting Patient-Reported Outcomes in Rheumatoid Arthritis 2016 ·JMIR Research Protocols ·Oscar Massimiliano Epis, (unknown), Laura Belloli, (unknown), Davide Filippini, Marina Muscarà, (unknown), (unknown), (unknown), (unknown), Irene Schiavetti, E Bruschi	14
18	Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis 2015 ·Journal of Neurology ·Letizia Leocani, Arturo Nuara, Elise Houdayer, Irene Schiavetti, Ubaldo Del Carro, Stefano Amadio, Laura Straffi, Paolo Rossi, Vittorio Martinelli, Carlos Vila, Maria Pia Sormani, Gıancarlo Comı	43
19	Effect of Diode Laser in the Treatment of Patients with Nonspecific Chronic Low Back Pain: A Randomized Controlled Trial 2014 ·Photomedicine and Laser Surgery ·(unknown), Stefano Benedicenti, (unknown), Irene Schiavetti, Francesca Angiero	34
20	Evaluation of the cephalometrics modification of growing Class II Division I patients after treatment with the PUL appliance: a pilot study. 2013 ·CINECA IRIS Institutial Research Information System (University of Genoa) ·Marco Migliorati, (unknown), Armando Silvestrini‐Biavati, Irene Schiavetti, Alessio Signori, Domenico Dalessandri, Alessandro Orsini, Antonino Patti, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact